Rana Al-hallaq
Director Board Of Directors at Autifony Therapeutics
New York City Metropolitan Area
Overview
Work Experience
Director Board Of Directors
2021 - Current
Observer Board of Directors
2021
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Raised $207,000,000.00 from AbbVie, Avalon Ventures, Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Pfizer Venture Investments and Versant Ventures.
Partner, Pfizer Ventures and Executive Director, Pfizer Worldwide Business Development
2021
Senior Director and Partner, Pfizer Ventures
2020 - 2021
Senior Director and Principal, Pfizer Ventures
2018 - 2020
Director Business Development
2016 - 2018
Early Candidate Clinical Lead
2015 - 2016
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
Director Board Of Directors
2021
Director Board Of Directors
2021
Director Board Of Directors
2021
RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.
Raised $675,100,000.00 from Catalio Capital Management, T. Rowe Price, Venrock, The Rise Fund, Squarepoint Capital, Pictet Private Equity Investors S.A., Pfizer Venture Investments, Ally Bridge Group, Hillenbrand Capital Partners, LLC. and Johnson & Johnson Innovation – JJDC.
Director Board Of Directors
2020
Observer Board of Directors
2019
Arkuda Therapeutics is a pharmaceutical company.
Raised $108,000,000.00 from Cormorant Asset Management, Pivotal bioVenture Partners, Pfizer Venture Investments, Surveyor Capital, Eli Lilly, Mission BioCapital, Tekla Capital Management and Atlas Venture.
Director Board Of Directors
2019
Director Board Of Directors
2019